Clinical Trial Update: GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study of GSK2647544 RD in healthy young and elderly volunteers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• GSK2647544 RD (GSK2647544)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alzheimer's Disease | Phase 1 | Status: TERMINATED